The PSD-95 inhibitor also had a favorable safety profile in phase III trial ...

Overall, women who stuck most closely to an eating pattern resembling the Mediterranean diet had an 18% lower risk of any ...

The rationale behind the treatment is that, because genetic FXI deficiency has been linked with reduced risk of ischemic ...

CHOICE-2 supports intra-arterial alteplase after successful reperfusion ...

Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...

The factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major or minor bleeding in patients ...

Harford County woman Sarah Bochenick's stroke recovery story highlights how quick medical response can save lives and prevent ...

With the study adding to a mix of conflicting trial results, it’s not yet time to update guidelines, Shyam Prabhakaran says.

As stroke systems of care evolve, clinicians are increasingly torn between the known safety of traditional, aggressive ...

An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...

Washington Regional earned three awards from the Arkansas Department of Health for outstanding performance in stroke patient ...